Caricamento...
MicroRNAs and other non-coding RNAs as targets for anticancer drug development
With the first cancer-targeted microRNA drug, MRX34, a liposome-based miR-34 mimic, entering phase I clinical trial in patients with advanced hepatocellular carcinoma in April 2013, miRNA therapeutics are attracting special attention from both academia and biotechnology companies. Although to date t...
Salvato in:
| Pubblicato in: | Nat Rev Drug Discov |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4548803/ https://ncbi.nlm.nih.gov/pubmed/24172333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrd4140 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|